Virology Laboratory Services
Schedule a Call
Comprehensive virology assays for antiviral and vaccine development
Our Virology services provide specialised assays to support antiviral drug development and vaccine research. We combine scientific depth with advanced technology to deliver accurate and reproducible virology data.
Our Services
-
TCID50 and Plaque Assays and Focus forming Assay (FFA) for viral quantification
-
Drug potency assays (IC50/IC90)
-
Viral neutralization and ligand binding assays
-
Resistance monitoring using NGS
Applications
-
Respiratory pathogen research
-
Emerging infectious disease programs
-
Antiviral drug development
Benefits
-
Validated virology workflows
-
High-throughput and automated processes
-
Regulatory-compliant assay execution
-
Comprehensive reporting
We offer a range of virology laboratory services to support research and clinical development, including viral detection, quantification, characterisation, and infectivity‑based assays. Our services are designed to support antiviral development, vaccine research, and translational and clinical studies.
Our virology capabilities support work with a wide range of viral pathogens and study models, using sample types such as respiratory samples, blood‑derived matrices, cell cultures, and clinical trial specimens. Services are tailored to study objectives and biosafety requirements.
All virology work is conducted within controlled laboratory environments using defined biosafety procedures and quality frameworks. We apply validated or fit‑for‑purpose methods, rigorous controls, and experienced scientific oversight to ensure reliable, reproducible data while maintaining high biosafety standards.
Plan your next Clinical Trial with hVIVO
If you're a potential customer, find out how hVIVO can help you.